<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A favorable prognosis and a low rate of leukemic transformation has been attributed to the <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q- syndrome</z:e>, a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) characterized by <z:hpo ids='HP_0001972'>macrocytic anemia</z:hpo>, hypolobulated micromegakaryocytic <z:mpath ids='MPATH_134'>hyperplasia</z:mpath>, and an interstitial deletion of chromosome 5 </plain></SENT>
<SENT sid="1" pm="."><plain>We examined the characteristics and outcome of 43 consecutive patients in our institution strictly defined by morphologic criteria and a solitary 5q- cytogenetic defect </plain></SENT>
<SENT sid="2" pm="."><plain>The median age at diagnosis was 68 years, with a clear female predominance (7:3) </plain></SENT>
<SENT sid="3" pm="."><plain>Eighty percent of the patients were red blood cell transfusion-dependent at diagnosis and <z:hpo ids='HP_0000001'>all</z:hpo> untransfused patients had macrocytic indexes </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, significant <z:hpo ids='HP_0001875'>neutropenia</z:hpo> or <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> was rare </plain></SENT>
<SENT sid="5" pm="."><plain>The French-American-British (FAB) class distributions were RA (72%), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> (7%), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> (16%), and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>-IT (5%) </plain></SENT>
<SENT sid="6" pm="."><plain>At a median follow-up of 31 months, 56% of the patients survive, with a projected median survival of 63 months </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence of <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> was 16% and was uniformly fatal </plain></SENT>
<SENT sid="8" pm="."><plain>Clinical <z:mp ids='MP_0005639'>hemosiderosis</z:mp> occurred in 28% of the patients, resulting in two <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Neither survival nor the risk of leukemic transformation was predictable from initial clinical parameters, including FAB classification, Bournemouth score, and degree of <z:mp ids='MP_0004024'>aneuploidy</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>The lack of significant <z:hpo ids='HP_0001875'>neutropenia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> seemed to account for a very low incidence of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and <z:mp ids='MP_0001914'>bleeding</z:mp> resulting in a prognosis equal or superior to historical patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Therapeutic endeavors, including the use of <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, <z:chebi fb="5" ids="50113">androgens</z:chebi>, cis-<z:chebi fb="2" ids="26536">retinoic acid</z:chebi>, <z:chebi fb="5" ids="16709">pyridoxine</z:chebi>, and <z:chebi fb="1" ids="4315">danazol</z:chebi>, were largely unsuccessful </plain></SENT>
</text></document>